Kronox Lab Sciences Limited
NSE: KRONOX · Unclassified
Ask the data
Instant answers about Kronox Lab Sciences Limited — computed from its filings, no language modelPrice & valuation
split & bonus adjusted · pick a metric and rangeAnnual performance
annual · ₹ crore · line = operating margin| FY24 | FY25 | FY26 | |
|---|---|---|---|
| Revenue | 89.9 | 100.2 | 101.2 |
| EBITDA | 28.3 | 33.1 | 34.3 |
| Operating margin | 31.5% | 33.1% | 33.9% |
| Interest | 0.0 | 0.0 | 0.1 |
| Depreciation | 1.3 | 1.4 | 2.0 |
| Profit before tax | 28.6 | 34.3 | 37.3 |
| Tax | 7.3 | 9.0 | 9.6 |
| Net profit | 21.4 | 25.3 | 27.7 |
| EPS ₹ | 5.81 | 6.91 | 7.51 |
| Operating cash flow | 17.4 | 32.5 | 23.9 |
| Capex | 12.3 | 3.1 | 3.3 |
| Dividend paid | 0.0 | 1.9 | 1.9 |
| Total assets | 74.0 | 98.8 | 127.5 |
| Equity | 66.3 | 90.1 | 116.1 |
Quarterly performance
last 11 quarters · ₹ crore| MAR '24 | JUN '24 | SEP '24 | DEC '24 | MAR '25 | JUN '25 | SEP '25 | DEC '25 | MAR '26 | JUN '26 | SEP '26* | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 22.2 | 25.2 | 24.9 | 24.0 | 26.1 | 24.3 | 25.5 | 25.3 | 26.1 | 28.4 | 26.8 |
| Operating profit | 7.9 | 8.2 | 8.8 | 8.4 | 7.8 | 8.0 | 8.7 | 8.0 | 9.5 | 9.0 | 8.4 |
| Operating margin | 35.4% | 32.6% | 35.4% | 34.8% | 29.7% | 32.8% | 33.9% | 31.7% | 36.4% | 31.7% | 31.5% |
| Other income | 0.8 | 0.4 | 0.4 | 0.8 | 0.9 | 0.9 | 1.0 | 1.1 | 2.1 | 1.3 | 0.9 |
| Interest | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 |
| Depreciation | 0.3 | 0.3 | 0.3 | 0.4 | 0.3 | 0.4 | 0.5 | 0.5 | 0.7 | 0.5 | 0.5 |
| Profit before tax | 8.4 | 8.3 | 8.8 | 8.8 | 8.3 | 8.4 | 9.2 | 8.6 | 11.0 | 9.8 | 8.7 |
| Tax | 2.5 | 2.2 | 2.4 | 2.3 | 2.0 | 2.2 | 2.5 | 2.0 | 3.0 | 2.5 | 2.3 |
| Net profit | 5.9 | 6.2 | 6.5 | 6.5 | 6.3 | 6.3 | 6.7 | 6.6 | 8.0 | 7.3 | 6.4 |
| EPS ₹ | 1.60 | 1.67 | 1.76 | 1.77 | 1.72 | 1.70 | 1.82 | 1.79 | 2.18 | 2.00 | 1.70 |
| Revenue YoY | — | — | — | — | 17.8% | -3.6% | 2.7% | 5.2% | 0.0% | 16.9% | 5.1% |
| Profit YoY | — | — | — | — | 7.5% | 2.1% | 3.2% | 0.9% | 26.6% | 16.2% | -3.6% |
Returns & margins
trailing-twelve-month, per quarter| DEC '24 | MAR '25 | JUN '25 | SEP '25 | DEC '25 | MAR '26 | JUN '26 | SEP '26 | |
|---|---|---|---|---|---|---|---|---|
| ROE | 32.4% | 28.3% | 28.4% | 25.5% | 25.5% | 23.7% | 24.6% | 22.1% |
| ROCE | 44.5% | 38.0% | 38.2% | 33.5% | 33.3% | 31.7% | 32.9% | 29.9% |
| Net margin | 26.0% | 25.4% | 25.8% | 25.8% | 25.6% | 27.2% | 27.1% | 26.6% |
| EBITDA margin | 34.5% | 33.1% | 33.1% | 32.7% | 32.0% | 33.7% | 33.4% | 32.8% |
| Debt / equity | 0.00 | 0.00 | 0.00 | 0.03 | 0.03 | 0.01 | 0.01 | 0.00 |
| Interest coverage | — | — | — | 870.00 | 432.62 | 310.92 | 258.07 | 201.58 |
| Asset turnover | 1.13 | 1.01 | 1.00 | 0.89 | 0.90 | 0.79 | 0.83 | 0.77 |
Balance sheet
equity vs borrowings over time · ₹ crore| MAR '24 | SEP '24 | MAR '25 | SEP '25 | MAR '26 | SEP '26 | |
|---|---|---|---|---|---|---|
| Share capital | 37.1 | 37.1 | 37.1 | 37.1 | 37.1 | 37.1 |
| Other equity / reserves | 29.2 | 40.0 | 53.0 | 64.3 | 79.0 | 90.9 |
| Total equity | 66.3 | 77.2 | 90.1 | 101.4 | 116.1 | 128.0 |
| Borrowings | 0.0 | 0.0 | 0.0 | 2.6 | 1.6 | 0.0 |
| Current liabilities | 7.7 | 8.0 | 0.6 | 9.9 | 10.4 | 9.9 |
| Non-current liabilities | 0.0 | 0.0 | 8.1 | 1.4 | 1.0 | 0.1 |
| Total assets | 74.0 | 85.2 | 98.8 | 112.7 | 127.5 | 138.1 |
| Property, plant & equipment | 26.4 | 26.2 | 27.9 | 29.7 | 28.7 | 28.7 |
| Capital work-in-progress | 0.5 | 2.3 | 0.8 | 0.8 | 0.9 | 1.8 |
| Investments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Inventories | 9.2 | 8.5 | 6.4 | 7.6 | 8.4 | 7.4 |
| Receivables | 17.6 | 21.3 | 19.9 | 20.5 | 21.2 | 18.8 |
| Cash & equivalents | 2.6 | 2.1 | 3.0 | 2.6 | 2.8 | 9.4 |
Cash flow
annual · ₹ crore · line = free cash flow| FY24 | FY25 | FY26 | |
|---|---|---|---|
| Cash from operations | 17.4 | 32.5 | 23.9 |
| Cash from investing | -17.3 | -30.2 | -23.8 |
| Cash from financing | 0.0 | -1.9 | -0.4 |
| Capex | 12.3 | 3.1 | 3.3 |
| Free cash flow | 5.1 | 29.4 | 20.6 |
| Dividends paid | 0.0 | 1.9 | 1.9 |
Where the assets sit
Sep '26 · ₹ crorePeer comparison
largest in Unclassified · this company in bold| Company | Market cap ₹cr | Price | P/E | P/B | ROE |
|---|---|---|---|---|---|
| Avantel Limited | 36,86,04,549 | 138.69 | — | 1059360.68 | 0.0% |
| Ducol Organics And Colours Limited | 19,55,275 | 120.00 | — | 20089.13 | 0.0% |
| Jio Platforms Limited | 12,57,181 | 1,406.40 | — | 3.57 | — |
| SBI Funds Management Limited | 1,01,750 | 499.55 | — | — | — |
| Tamilnadu Telecommunication Limited | 91,314 | 9.93 | — | — | — |
| Manipal Health Enterprises Limited | 76,294 | 646.70 | — | — | — |
| INDO-MIM Limited | 59,042 | 1,219.50 | — | — | — |
| AvenuesAI Limited | 45,138 | 129.25 | 153.6 | 9.51 | 6.2% |
| Dhoot Transmission Limited | 32,761 | 1,601.60 | — | 8.11 | — |
| 3M India Limited | 31,071 | 27,570.00 | 53.8 | 17.57 | 32.7% |
| Kronox Lab Sciences Limited | 721 | 194.32 | 25.5 | 5.63 | 22.1% |
StoxGud checklist: Bullish setup · 8/10
- Price above 50-day average
- Price above 200-day average
- 50-day average above 200-day (uptrend)
- RSI in healthy 40–70 zone
- Positive 1-year return
- Return on equity above 15%
- Debt to equity below 1
- Revenue growing year on year
- Net profit margin above 10%
- P/E below industry median
A rules-based screen of trend, momentum, quality and valuation. Educational only — not a buy or sell recommendation.
Returns & technicals
FAQs
What is the share price of Kronox Lab Sciences Limited?
Kronox Lab Sciences Limited (KRONOX) closed at ₹194.32 on NSE on 06 Nov 2026.
What is the market cap of Kronox Lab Sciences Limited?
₹721 crore at the latest close.
What is the P/E ratio of Kronox Lab Sciences Limited?
25.5, on trailing-twelve-month earnings from its filings.
How fast is Kronox Lab Sciences Limited growing?
Kronox Lab Sciences Limited: Latest-quarter revenue is up 5.1% year on year, profit down 3.6%.
How profitable is Kronox Lab Sciences Limited?
On a trailing-twelve-month basis return on equity is 22.1%, return on capital employed 29.9%, operating margin 32.8%, net margin 26.6%.
How much debt does Kronox Lab Sciences Limited have?
Kronox Lab Sciences Limited is debt-free: debt to equity is 0.00 with borrowings of ₹0 cr against cash of ₹9 cr (balance sheet of 2026-09-30). Operating profit covers interest 201.6 times.
Financials parsed from Kronox Lab Sciences Limited's own XBRL filings to NSE (standalone), ₹ crore unless marked. Quarterly from MAR '24, annual from FY24, balance sheet from Mar '24. * = derived (full year or half year minus earlier quarters). Information only, not investment advice.